Cargando…
Apoptotic mechanisms in T47D and MCF-7 human breast cancer cells
To investigate the mechanisms underlying apoptosis in breast cancer cells, staurosporine was used as an apoptotic stimulus in the human breast cancer cell lines MCF-7 and T47D. Staurosporine induced dose and time dependent increases in DNA fragmentation which was abrogated by z-VAD-fmk. MCF-7 cells...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376174/ https://www.ncbi.nlm.nih.gov/pubmed/12373608 http://dx.doi.org/10.1038/sj.bjc.6600541 |
_version_ | 1782154707434733568 |
---|---|
author | Mooney, L M Al-Sakkaf, K A Brown, B L Dobson, P R M |
author_facet | Mooney, L M Al-Sakkaf, K A Brown, B L Dobson, P R M |
author_sort | Mooney, L M |
collection | PubMed |
description | To investigate the mechanisms underlying apoptosis in breast cancer cells, staurosporine was used as an apoptotic stimulus in the human breast cancer cell lines MCF-7 and T47D. Staurosporine induced dose and time dependent increases in DNA fragmentation which was abrogated by z-VAD-fmk. MCF-7 cells did not express caspase-3, suggesting that DNA fragmentation occurred in the absence of caspase-3 and that other caspases may be involved. Staurosporine induced DEVDase activity in T47D cells suggesting the involvement of caspase-3 and/or caspase-7, yet there was no DEVDase activity in MCF-7 cells, probably ruling out the involvement caspase-7. However, staurosporine induced the cleavage of pro-caspase-6 in MCF-7 cells, but not in T47D cells. Caspase dependent PARP cleavage was detected in MCF-7 cells at 3 h, whereas only partial PARP cleavage was detected in T47D cells and then only after 24 h. Moreover, staurosporine led to cytochrome c release at 2 h in MCF-7 cells and 6 h in T47D cells. In addition, a time dependent and caspase-independent reduction of the mitochondrial transmembrane potential was observed; which appeared to occur after the release of cytochrome c. Translocation of Bax from the cytosol to mitochondria was observed in both cell types, and this preceded cytochrome c release in both T47D and MCF-7 cells. Apoptotic events in both cell types differ temporally, involving activation of different caspases and mitochondrial changes. British Journal of Cancer (2002) 87, 909–917. doi:10.1038/sj.bjc.6600541 www.bjcancer.com © 2002 Cancer Research UK |
format | Text |
id | pubmed-2376174 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2002 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-23761742009-09-10 Apoptotic mechanisms in T47D and MCF-7 human breast cancer cells Mooney, L M Al-Sakkaf, K A Brown, B L Dobson, P R M Br J Cancer Experimental Therapeutics To investigate the mechanisms underlying apoptosis in breast cancer cells, staurosporine was used as an apoptotic stimulus in the human breast cancer cell lines MCF-7 and T47D. Staurosporine induced dose and time dependent increases in DNA fragmentation which was abrogated by z-VAD-fmk. MCF-7 cells did not express caspase-3, suggesting that DNA fragmentation occurred in the absence of caspase-3 and that other caspases may be involved. Staurosporine induced DEVDase activity in T47D cells suggesting the involvement of caspase-3 and/or caspase-7, yet there was no DEVDase activity in MCF-7 cells, probably ruling out the involvement caspase-7. However, staurosporine induced the cleavage of pro-caspase-6 in MCF-7 cells, but not in T47D cells. Caspase dependent PARP cleavage was detected in MCF-7 cells at 3 h, whereas only partial PARP cleavage was detected in T47D cells and then only after 24 h. Moreover, staurosporine led to cytochrome c release at 2 h in MCF-7 cells and 6 h in T47D cells. In addition, a time dependent and caspase-independent reduction of the mitochondrial transmembrane potential was observed; which appeared to occur after the release of cytochrome c. Translocation of Bax from the cytosol to mitochondria was observed in both cell types, and this preceded cytochrome c release in both T47D and MCF-7 cells. Apoptotic events in both cell types differ temporally, involving activation of different caspases and mitochondrial changes. British Journal of Cancer (2002) 87, 909–917. doi:10.1038/sj.bjc.6600541 www.bjcancer.com © 2002 Cancer Research UK Nature Publishing Group 2002-10-07 2002-10-07 /pmc/articles/PMC2376174/ /pubmed/12373608 http://dx.doi.org/10.1038/sj.bjc.6600541 Text en Copyright © 2002 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Experimental Therapeutics Mooney, L M Al-Sakkaf, K A Brown, B L Dobson, P R M Apoptotic mechanisms in T47D and MCF-7 human breast cancer cells |
title | Apoptotic mechanisms in T47D and MCF-7 human breast cancer cells |
title_full | Apoptotic mechanisms in T47D and MCF-7 human breast cancer cells |
title_fullStr | Apoptotic mechanisms in T47D and MCF-7 human breast cancer cells |
title_full_unstemmed | Apoptotic mechanisms in T47D and MCF-7 human breast cancer cells |
title_short | Apoptotic mechanisms in T47D and MCF-7 human breast cancer cells |
title_sort | apoptotic mechanisms in t47d and mcf-7 human breast cancer cells |
topic | Experimental Therapeutics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376174/ https://www.ncbi.nlm.nih.gov/pubmed/12373608 http://dx.doi.org/10.1038/sj.bjc.6600541 |
work_keys_str_mv | AT mooneylm apoptoticmechanismsint47dandmcf7humanbreastcancercells AT alsakkafka apoptoticmechanismsint47dandmcf7humanbreastcancercells AT brownbl apoptoticmechanismsint47dandmcf7humanbreastcancercells AT dobsonprm apoptoticmechanismsint47dandmcf7humanbreastcancercells |